Health ❯Diseases ❯Neurological Disorders
Genetic Factors Glial Progenitor Cells Glial Cells Protein Function Disease Progression Monitoring
Early results from a small Phase 1/2 study using external natural‑history controls will guide an FDA filing planned for early 2026.